Media coverage
2
Media coverage
Title Aeglea BioTherapeutics Announces New Positive Phase 1/2 Data for Pegzilarginase in Patients with Arginase 1 Deficiency at 2019 Annual Meeting of the Society for Inherited Metabolic Disorders Media name/outlet Global English (Middle East and North Africa Financial Network) Country/Territory Jordan Date 7/04/19 Persons George Diaz Title Aeglea BioTherapeutics Announces New Positive Phase 1/2 Data for Pegzilarginase in Patients with Arginase 1 Deficiency at 2019 Annual Meeting of the Society for Inherited Metabolic Disorders Nasdaq:AGLE Media name/outlet Global English (Middle East and North Africa Financial Network) Country/Territory Jordan Date 7/04/19 Persons George Diaz